Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATOS | TMO | ISRG | EW | DXCM |
| Company | Atossa Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.3200 | 549.15 | 369.54 | 86.54 | 131.26 |
| High | 1.4700 | 552.86 | 371.83 | 87.11 | 132.36 |
| Low | 1.3200 | 543.15 | 364.31 | 85.73 | 129.74 |
| Last | 1.4200 | 548.38 | 368.93 | 86.96 | 131.52 |
| Change | +0.0500 | +3.60 | +2.59 | +1.02 | +0.81 |
| % Change | +3.65% | +0.66% | +0.71% | +1.19% | +0.62% |
| Volume | 1,020,500 | 1,522,800 | 1,603,100 | 2,408,000 | 2,110,300 |
| 20-Day Average Volume | 3,001,100 | 1,309,810 | 1,600,160 | 3,019,005 | 2,514,615 |
| Previous Close | 1.3700 | 544.78 | 366.34 | 85.94 | 130.71 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7368 | 567.70 | 384.89 | 91.36 | 137.08 |
| 20-Day Raw Stochastic | 16.82% | 31.08% | 12.02% | 14.71% | 18.32% |
| 20-Day Relative Strength | 47.76% | 41.13% | 41.63% | 44.01% | 48.32% |
| Weighted Alpha | +80.34 | +1.53 | +23.29 | +4.89 | +15.35 |
| Today's Opinion | 72% Buy | 24% Buy | 40% Buy | 56% Buy | 80% Buy |
| Previous Opinion | 56% Buy | 24% Buy | 40% Buy | 56% Buy | 80% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.96% since 04/15/24 | -1.70% since 04/15/24 | -2.23% since 04/15/24 | -2.51% since 04/15/24 | -2.26% since 04/15/24 |
| Low | 1.2400 on 04/18/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 129.17 on 04/19/24 |
| High | 1.6900 on 04/16/24 | 559.04 on 04/16/24 | 388.65 on 04/19/24 | 90.40 on 04/16/24 | 137.82 on 04/16/24 |
| 1-Month | |||||
| %Chg | -14.97% since 03/22/24 | -5.95% since 03/22/24 | -6.38% since 03/22/24 | -7.28% since 03/22/24 | -1.25% since 03/22/24 |
| Low | 1.2400 on 04/18/24 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 85.38 on 04/19/24 | 129.17 on 04/19/24 |
| High | 2.3100 on 04/05/24 | 589.93 on 04/09/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 3-Month | |||||
| %Chg | +73.81% since 01/22/24 | -0.91% since 01/22/24 | -1.83% since 01/22/24 | +15.70% since 01/22/24 | +1.72% since 01/22/24 |
| Low | 0.7744 on 01/25/24 | 529.64 on 04/18/24 | 362.14 on 01/24/24 | 71.92 on 01/25/24 | 113.05 on 02/28/24 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | +115.15% since 10/20/23 | +18.09% since 10/20/23 | +38.22% since 10/20/23 | +25.16% since 10/20/23 | +52.98% since 10/20/23 |
| Low | 0.6200 on 11/13/23 | 415.60 on 10/25/23 | 254.85 on 10/30/23 | 60.57 on 10/30/23 | 80.93 on 10/26/23 |
| High | 2.3100 on 04/05/24 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 177,932 | 209,324,320 | 130,766,872 | 52,343,568 | 50,702,936 |
| Shares Outstanding, K | 125,304 | 381,714 | 354,449 | 601,927 | 385,515 |
| Annual Sales | 0 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -30,090,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 0 | 10,886,000,000 | 1,890,600,000 | 1,534,100,000 | 1,034,500,000 |
| Last Quarter Net Income | -7,750,000 | 1,630,000,000 | 544,900,000 | 369,900,000 | 256,300,000 |
| 60-Month Beta | 1.19 | 0.80 | 1.36 | 1.05 | 1.20 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 04/01/24 | 5.67 on 01/31/24 | 1.50 on 04/18/24 | 0.64 on 02/06/24 | 0.50 on 02/08/24 |
| Latest Earnings Date | 05/20/24 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.29 | 78.28 | 34.24 | 86.56 |